NCT07067775

Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Jiangsu vcare pharmaceutical technology co., LTD · Industry
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

This clinical study will adopt an open-label, randomized, two-crossover design to explore the pharmacokinetic and pharmacodynamic profiles of Vicagrel Capsules and Clopidogrel Tablets in Healthy Subjects with CYP2C19 Normal Metabolizers

Conditions

• Acute Coronary Syndrome

Interventions

Type	Name	Description
DRUG	Vicagrel Capsules	Vicagrel Capsules qd per period, for two periods
DRUG	Clopidogrel Tablets	Clopidogrel Tablets qd per period, for two periods

Timeline

• Start date: 2025-08-05
• Primary completion: 2025-08-22
• Completion: 2025-08-22
• First posted: 2025-07-16
• Last updated: 2025-09-09

Locations

1 site across 1 country: China